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Introduction
Malakoplakia was first announced by Michaelis and Gut-
mann in 1902 and named the lesion malakoplakia from 
Greek malakos (soft), and plaka (plaque) by Vom Hansemann 
in 1903. Malakoplakia is a rare non-malignant inflamma-
tory granulomatous disease that most commonly affects the 
genitourinary tract, but the involvement of other organs has 
also been reported [1]. Even though the pathogenesis is not 
completely known, a number of cases accompany bacterial 
infection in the pelvic and as a result, is diagnosed as tubo-
ovarian abscess (TOA) at first. The theories about etiology 
include bacterial infection and abnormal immune response 
such as abnormal function of macrophage. The immunologic 
theory also explains the fact that the most commonly af-
fected patients are the immune-suppressed ones [2,3].
The treatment of malakoplakia includes medical treatment 
such as antibiotics, surgical treatment, and sometimes with-
drawal of immunosuppressive therapy [3]. Prognosis depends 
on not only the severity, location and extent of the disease 
but also the general health of the patients before the diag-
nosis.
We present a case which was first suspected as a severe 
infection involving left ovary and salpinx and as endometrial 
cancer later. After coming to our hospital, debulking surgery 
was done and the pathologist diagnosed her as malako-
plakia. With conservative management including proper 
antibiotics after the surgery, she was fully recovered and dis-
charged without her chronic pelvic pain.
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Case report
A 52-year-old woman presented with intermittent left lower 
quadrant pain that had started in 2017. She was diagnosed 
with systemic lupus erythematosus 19 years ago and had 
been taking oral corticosteroids since then. Her past medical 
history also showed steroid-induced diabetes mellitus, hyper-
tension, and hypothyroidism, which was treated with levo-
thyroxine. Menopause occurred when she was in her thirties.
On her first visit to the emergency department in another 
tertiary hospital in May 2018, she underwent abdominal pel-
vic computerized tomography (APCT), which showed a mul-
tiloculated lesion on the left adnexa, with left ovary involve-
ment and hydrosalpinx or pyosalpinx. Under the impression 
of a TOA, she was admitted and received conservative care 
including intravenous (IV) antibiotics for 15 days. However, 
the pain in her left lower quadrant persisted. She visited the 
emergency department for the second time in July 2018. 
APCT was performed again, which revealed a slightly in-
creased multiloculated, rim-enhancing lesion compared with 
the previous APCT findings. Again, the impression was TOA; 
however, APCT showed a newly developed wall enhance-
ment of the left ureter due to either secondary change or 
combined ureteritis. Because of persistent pain, she agreed 
to undergo surgery. On August 3, 2018, the patient under-
went laparoscope-guided bilateral salpingo-oophorectomy. 
The pathology report showed chronic active inflammation 
with foam cell collection in her left ovary and both salpinges.
Because the surgery did not alleviate her pain, she un-
derwent both APCT and magnetic resonance imaging in 
April 2019, which revealed a 7-cm irregular mass in her left 
adnexa and an infiltrative lesion in her uterus, suggestive of 
endometrial cancer. Imaging results also showed left ureter 
invasion by the left adnexal tumor. As prophylactic manage-
ment, a left ureter stent was inserted. Furthermore, she un-
derwent dilatation and curettage for diagnosis. Pathological 
examination showed chronic active inflammation with foam 
cell collection, consistent with the finding in the previous 
laparoscopic surgery.
The patient visited the emergency department of our 
hospital on May 20, 2019. She had sepsis and a body tem-
perature of >39°C; blood culture revealed the presence of 
extended-spectrum beta-lactamase–producing Escherichia 
coli. The cervix culture taken at the emergency department 
also showed the presence of the same organism. Her initial 
blood urea nitrogen level was 45.6 mg/dL, and her creatinine 
level was 2.75 mg/dL, which implied septic postrenal acute 
kidney injury. For septic shock evaluation, she underwent 
APCT without contrast, which revealed newly developed 
mild hydronephrosis of the left kidney. The left adnexal mass 
remained the same as that seen in April 2019 (Fig. 1). We 
started initial shock management in the emergency depart-
ment and conservative care including an IV antibiotic (me-
ropenem) for bacteremia and left percutaneous nephrostomy 
(PCN) for left hydronephrosis and acute kidney injury.
After her recovery from septic shock, the patient under-
went debulking surgery on June 4, 2019. During the surgery, 
severe adhesion in the pelvis involving the peritoneum, rec-
tum, uterus, and left ureter was noted. Multiple hard and 
catheter-shaped foreign body–like materials were observed 
in the left parametrium and left pararectal space and near 
the left internal iliac artery. Caseous necrotic materials had 
spread deep into the left pelvic and paravaginal space. To-
tal hysterectomy and debulking operation of the left pelvic 
mass, including left pelvic lymph nodes, were performed.
The final pathology showed foamy histiocyte aggregation 
Fig. 1. (A) The patient’s preoperative abdominal pelvic computerized tomography (APCT) depicting the pelvic mass (coronal view and 
horizontal view). (B) Postoperative day #9 APCT depicting the recurred pelvic mass (coronal view and horizontal view).
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and acute and chronic inflammation with numerous Michae-
lis-Gutmann bodies, consistent with malakoplakia (Fig. 2). 
According to the recommended treatment for malakoplakia, 
we continued IV administration of tazoperan after the sur-
gery. After the culture from peritoneal fluid cytology showed 
ceftazidime-sensitive E. coli, we changed the antibiotic to 
ceftazidime 1 g twice a day.
However, her creatinine level increased gradually to 4.48 
mg/dL after the surgery. A retrograde pyelogram showed 
patent left ureter and dye spillage from the right ureter. 
Right PCN was performed. A computerized tomography scan 
performed on postoperative day 9 showed recurrence of a 
9-cm mass in her left pelvis. Hence, we again administered 
tazoperan. On postoperative day 21, the patient was referred 
to a general hospital for further conservative care with IV an-
tibiotics.
On July 24, approximately 1.5 months after surgery, she 
underwent left PCN removal and right PCN clamping. On 
August 2, the patient returned to the emergency depart-
ment with complaints of fever and right flank pain that had 
started on the previous day. She presented with right cos-
tovertebral angle tenderness and pyuria and was admitted 
to the urology department with a diagnosis of right acute 
pyelonephritis. On August 9, the anterograde pyelogram 
showed leakage at the right ureter, which was similar to the 
previous retrograde pyelogram finding. Right PCN exchange 
was performed. After conservative care with IV antibiotics, 
the patient was discharged on August 12. On September 10, 
direct ureteroneocystostomy was attempted; however, only 
right PCN exchange was performed because the ureter was 
short.
The patient has been closely followed up through outpa-
tient visits to both urology and obstetrics and gynecology 
departments.
Discussion
Malakoplakia is a rare chronic inflammatory disease that 
usually affects the genitourinary tract [1], but it can affect 
any part of the body. However, its pathogenesis remains 
unknown. The disease usually occurs in immunosuppressed 
patients such as those with diabetes mellitus or those taking 
oral corticosteroids for rheumatic disease or immunosuppres-
sants due to organ transplantation and autoimmune disease. 
Because of its characteristics, malakoplakia is assumed to be 
related to a defect in macrophage function against bacterial 
infection [2,3].
In this case, malakoplakia resulted from bacterial infection 
in the pelvis that was first diagnosed as TOA and immuno-
suppression due to oral steroids and diabetes mellitus. Mala-
koplakia can affect various organs including the skin, lungs, 
and bones [4,5]. A literature review showed several reports 
of malakoplakia occurring in female pelvic organs involving 
the ovary and fallopian tube [6,7]; however, this is a very rare 
case of pelvic malakoplakia in the uterus without adnexa due 
to previous surgery and involving the full depth of the uterus, 
thus mimicking endometrial cancer as detected in imaging 
studies.
The diagnosis of malakoplakia is confirmed histologically 
after biopsy or surgery based on its pathognomonic features 
of von Hansemann histiocytes and Michaelis-Gutmann bod-
ies, which are monocytes or macrophages containing undi-
gested bacterial components including calcium [8].
The bladder is one of the organs most commonly affected 
with malakoplakia. Immunosuppressed patients such as 
those who underwent renal transplantation initially show 
hematuria or irritative symptoms [9]. However, malakoplakia 
affecting the female pelvis may not show disease-specific 
symptoms but rather general symptoms such as abdominal 
Fig. 2. (A, B) Foamy epithelioid histiocytes and some lymphocytes in endomyometrium and pelvic cavity (A: hematoxylin and eosin [H&E] 
stain, ×100, B: H&E stain, ×200). (C) Histiocytes with basophilic bodies containing calcium (H&E stain, ×400). (D) Michaelis-Gutmann 
bodies noted (Von Kossa stain, ×400).
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pain and mild fever. Without clinical suspicion in immuno-
suppressed patients, diagnosis can be delayed, thus increas-
ing morbidity, as noted in this case.
The treatment of choice for malakoplakia is conservative 
care with IV antibiotics as soon as possible to prevent disease 
progression. Reduction of immunosuppression in addition to 
IV antibiotics should be considered if possible. The treatment 
period or regimen is not yet established. However, recent 
case studies have reported the use of IV broad-spectrum 
antibiotics for longer than 2 months [9-11]. If the lesion is 
localized to one organ, medical treatment is recommended; 
however, surgical resection followed by IV antibiotics should 
be considered if the disease forms a mass.
Because malakoplakia is a rare disease, physicians should 
have clinical suspicion for precise diagnosis. Without such 
awareness, examinations and imaging studies may lead to an 
incorrect diagnosis, as in this case. In this case, the patient 
showed only low abdominal pain, and she was initially diag-
nosed with TOA. Her pathologic report from the first surgery 
showed only chronic inflammation, and she was treated with 
IV antibiotics for only 2 weeks. The short treatment period 
allowed disease progression. Therefore, careful history review 
and physical examination are necessary. Malakoplakia pres-
ents as a hard and solid mass containing nodules, which is 
similar to malignant tumors in imaging studies. However, it 
can be differentiated by pathologic examination.
This report illustrates a case that was assumed to be endo-
metrial cancer based on imaging studies but was diagnosed 
as pelvic malakoplakia after surgical resection. Because com-
plications and morbidity increase with incorrect treatment, 
malakoplakia should be carefully diagnosed and treated. 
Malakoplakia should be suspected in immunosuppressed 
patients showing symptoms of infection, and differential di-
agnosis is therefore required.
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